共 234 条
[1]
Anker SD(1997)Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia Circulation 96 526-534
[2]
Chua TP(2004)Cardiac cachexia Ann Med 36 518-529
[3]
Ponikowski P(2009)Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice J Clin Invest 119 3597-3612
[4]
Harrington D(2008)Biomarkers in heart failure N Engl J Med 358 2148-2159
[5]
Swan JW(2000)Congestive heart failure: fifty years of progress Circulation 102 IV14-IV23
[6]
Kox WJ(2003)Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes Mol Endocrinol 17 1640-1646
[7]
Poole-Wilson PA(2002)Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure Circulation 106 2491-2496
[8]
Coats AJ(1998)Catecholamines: the cardiovascular and neuroendocrine system Eur Heart J 19 F2-F6
[9]
Anker SD(1999)The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 9-13
[10]
Steinborn W(1984)Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 819-823